Adjuvant 32P in the treatment of ovarian carcinoma.

Condra, K S

Adjuvant 32P in the treatment of ovarian carcinoma. [electronic resource] - Radiation oncology investigations 1997 - 300-4 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article

1065-7541

10.1002/(SICI)1520-6823(1997)5:6<300::AID-ROI6>3.0.CO;2-1 doi


Adult
Aged
Aged, 80 and over
Disease-Free Survival
Female
Follow-Up Studies
Humans
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Ovarian Neoplasms--mortality
Phosphorus Radioisotopes--adverse effects
Prognosis
Radiotherapy, Adjuvant
Survival Rate